Table of contents

June 2017 - Volume 2 - 2


A

  1. Aas, Eline

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  2. Agnelli, Giancarlo

    1. Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options
      Cihan Ay, Pieter Willem Kamphuisen, Giancarlo Agnelli
  3. Ay, Cihan

    1. Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options
      Cihan Ay, Pieter Willem Kamphuisen, Giancarlo Agnelli

B

  1. Badoual, Cecile

    1. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
      Clemence Granier, Eleonore De Guillebon, Charlotte Blanc, Helene Roussel, Cecile Badoual, Elia Colin, Antonin Saldmann, Alain Gey, Stephane Oudard, Eric Tartour
  2. Barbato, Enrico

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  3. Barberis, Massimo

    1. External quality assessment for EGFR mutations in Italy: improvements in performances over the time
      Nicola Normanno, Francesca Fenizia, Francesca Castiglione, Massimo Barberis, Gian Luigi Taddei, Mauro Truini, Gaetano De Rosa, Carmine Pinto, Antonio Marchetti
  4. Barzelloni, Maria Luisa

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  5. Beiske, Klaus

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  6. Bellmunt, Joaquim

    1. New treatment options for metastatic renal cell carcinoma
      Alejo Rodriguez-Vida, Thomas E Hutson, Joaquim Bellmunt, Michiel H Strijbos
  7. Bergheim, Inger R

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  8. Berghoff, Anna S

    1. CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology
      Matthias Preusser, Anna S Berghoff, Christiane Thallinger, Christoph Zielinski
  9. Berrino, Liberato

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
  10. Blanc, Charlotte

    1. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
      Clemence Granier, Eleonore De Guillebon, Charlotte Blanc, Helene Roussel, Cecile Badoual, Elia Colin, Antonin Saldmann, Alain Gey, Stephane Oudard, Eric Tartour
  11. Boye, Kjetil

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  12. Bria, Emilio

    1. Biosimilars as a strategy to improve sustainability
      Emilio Bria, Pierfranco Conte
  13. Børresen-Dale, Anne-Lise

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark

C

  1. Caleno, Mariapaola

    1. European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer
      Stefan Cristian Stanel, Jan Sjöberg, Tomas Salmonson, Paolo Foggi, Mariapaola Caleno, Daniela Melchiorri, Iordanis Gravanis, Kyriaki Tzogani, Francesco Pignatti
  2. Capuano, Annalisa

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
  3. Caputo, Roberta

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  4. Castiglione, Francesca

    1. External quality assessment for EGFR mutations in Italy: improvements in performances over the time
      Nicola Normanno, Francesca Fenizia, Francesca Castiglione, Massimo Barberis, Gian Luigi Taddei, Mauro Truini, Gaetano De Rosa, Carmine Pinto, Antonio Marchetti
  5. Cerny, Thomas

    1. Multiple primary tumours: challenges and approaches, a review
      Alexia Vogt, Sabine Schmid, Karl Heinimann, Harald Frick, Christian Herrmann, Thomas Cerny, Aurelius Omlin
  6. Cervantes, Andrés

    1. In the literature: April 2017
      Andrés Cervantes
  7. Chen, Bo

    1. The effect of adjuvant chemotherapy in male breast cancer: 134 cases from a retrospective study
      Xing-Fei Yu, Chen Wang, Bo Chen, Chen-lu Liang, Dao-bao Chen, Yang Yu, Hong-jian Yang
  8. Chen, Dao-bao

    1. The effect of adjuvant chemotherapy in male breast cancer: 134 cases from a retrospective study
      Xing-Fei Yu, Chen Wang, Bo Chen, Chen-lu Liang, Dao-bao Chen, Yang Yu, Hong-jian Yang
  9. Ciardiello, Fortunato

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
    2. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  10. Colin, Elia

    1. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
      Clemence Granier, Eleonore De Guillebon, Charlotte Blanc, Helene Roussel, Cecile Badoual, Elia Colin, Antonin Saldmann, Alain Gey, Stephane Oudard, Eric Tartour
  11. Conte, Pierfranco

    1. Biosimilars as a strategy to improve sustainability
      Emilio Bria, Pierfranco Conte
  12. Curioni-Fontecedro, Alessandra

    1. A new era of oncology through artificial intelligence
      Alessandra Curioni-Fontecedro

D

  1. Da Meda, Laetitia

    1. Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
      Baptiste Louveau, Jörg Tost, Florence Mauger, Aurélie Sadoux, Marie-Pierre Podgorniak, Alexandre How-Kit, Cécile Pages, Jennifer Roux, Laetitia Da Meda, Céleste Lebbe, Samia Mourah
  2. De Guillebon, Eleonore

    1. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
      Clemence Granier, Eleonore De Guillebon, Charlotte Blanc, Helene Roussel, Cecile Badoual, Elia Colin, Antonin Saldmann, Alain Gey, Stephane Oudard, Eric Tartour
  3. De Rosa, Gaetano

    1. External quality assessment for EGFR mutations in Italy: improvements in performances over the time
      Nicola Normanno, Francesca Fenizia, Francesca Castiglione, Massimo Barberis, Gian Luigi Taddei, Mauro Truini, Gaetano De Rosa, Carmine Pinto, Antonio Marchetti
  4. Della Corte, Carminia Maria

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
  5. Di Liello, Raimondo

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
  6. Diana, Anna

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  7. Douillard, Jean-Yves

    1. ESMO Copenhagen 2016: a lung cancer ‘grand cru’
      Jean-Yves Douillard
  8. Dueland, Svein

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark

E

  1. Esposito, Giovanna

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello

F

  1. Fabozzi, Alessio

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  2. Fasano, Morena

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
  3. Febbraro, Antonio

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  4. Fenizia, Francesca

    1. External quality assessment for EGFR mutations in Italy: improvements in performances over the time
      Nicola Normanno, Francesca Fenizia, Francesca Castiglione, Massimo Barberis, Gian Luigi Taddei, Mauro Truini, Gaetano De Rosa, Carmine Pinto, Antonio Marchetti
  5. Ferraro, Danielle

    1. Discussing and prescribing expensive unfunded anticancer drugs in Australia
      Deme John Karikios, Linda Mileshkin, Andrew Martin, Danielle Ferraro, Martin R Stockler
  6. Fiorelli, Alfonso

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
  7. Flatmark, Kjersti

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  8. Flørenes, Vivi Ann

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  9. Foggi, Paolo

    1. European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer
      Stefan Cristian Stanel, Jan Sjöberg, Tomas Salmonson, Paolo Foggi, Mariapaola Caleno, Daniela Melchiorri, Iordanis Gravanis, Kyriaki Tzogani, Francesco Pignatti
  10. Frick, Harald

    1. Multiple primary tumours: challenges and approaches, a review
      Alexia Vogt, Sabine Schmid, Karl Heinimann, Harald Frick, Christian Herrmann, Thomas Cerny, Aurelius Omlin
  11. Fujiwara, Yasuhiro

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura

G

  1. Geitvik, Gry A

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  2. Genua, Geppino

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  3. Gey, Alain

    1. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
      Clemence Granier, Eleonore De Guillebon, Charlotte Blanc, Helene Roussel, Cecile Badoual, Elia Colin, Antonin Saldmann, Alain Gey, Stephane Oudard, Eric Tartour
  4. Giordano, Guido

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  5. Granier, Clemence

    1. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
      Clemence Granier, Eleonore De Guillebon, Charlotte Blanc, Helene Roussel, Cecile Badoual, Elia Colin, Antonin Saldmann, Alain Gey, Stephane Oudard, Eric Tartour
  6. Gravanis, Iordanis

    1. European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer
      Stefan Cristian Stanel, Jan Sjöberg, Tomas Salmonson, Paolo Foggi, Mariapaola Caleno, Daniela Melchiorri, Iordanis Gravanis, Kyriaki Tzogani, Francesco Pignatti
  7. Gravina, Adriano

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  8. Grimaldi, Giuseppe

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello

H

  1. Hagene, Kirsten T

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  2. Heinimann, Karl

    1. Multiple primary tumours: challenges and approaches, a review
      Alexia Vogt, Sabine Schmid, Karl Heinimann, Harald Frick, Christian Herrmann, Thomas Cerny, Aurelius Omlin
  3. Heinrich, Daniel

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  4. Henon, Clémence

    1. Patient-reported tolerability of adverse events in phase 1 trials
      Clémence Henon, Delphine Lissa, Xavier Paoletti, Constance Thibault, Christophe Le Tourneau, Emilie Lanoy, Antoine Hollebecque, Christophe Massard, Jean-Charles Soria, Sophie Postel-Vinay
  5. Herrmann, Christian

    1. Multiple primary tumours: challenges and approaches, a review
      Alexia Vogt, Sabine Schmid, Karl Heinimann, Harald Frick, Christian Herrmann, Thomas Cerny, Aurelius Omlin
  6. Hildebrandt, Sabine

    1. Where do they come from? A call for complete transparency regarding the origin of human tissues in research
      Sabine Hildebrandt, William E Seidelman
  7. Hollebecque, Antoine

    1. Patient-reported tolerability of adverse events in phase 1 trials
      Clémence Henon, Delphine Lissa, Xavier Paoletti, Constance Thibault, Christophe Le Tourneau, Emilie Lanoy, Antoine Hollebecque, Christophe Massard, Jean-Charles Soria, Sophie Postel-Vinay
  8. Hovig, Eivind

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  9. How-Kit, Alexandre

    1. Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
      Baptiste Louveau, Jörg Tost, Florence Mauger, Aurélie Sadoux, Marie-Pierre Podgorniak, Alexandre How-Kit, Cécile Pages, Jennifer Roux, Laetitia Da Meda, Céleste Lebbe, Samia Mourah
  10. Hutson, Thomas E

    1. New treatment options for metastatic renal cell carcinoma
      Alejo Rodriguez-Vida, Thomas E Hutson, Joaquim Bellmunt, Michiel H Strijbos

I

  1. Incoronato, Pasquale

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  2. Iodice, Giovanni

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello

J

  1. Johansen, Christin

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  2. Johnsen-Soriano, Siv

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  3. Julsrud, Lars

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark

K

  1. Kamphuisen, Pieter Willem

    1. Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options
      Cihan Ay, Pieter Willem Kamphuisen, Giancarlo Agnelli
  2. Karikios, Deme John

    1. Discussing and prescribing expensive unfunded anticancer drugs in Australia
      Deme John Karikios, Linda Mileshkin, Andrew Martin, Danielle Ferraro, Martin R Stockler
  3. Kinoshita, Takayuki

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura
  4. Kitano, Atsuko

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura
  5. Kodaira, Makoto

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura

L

  1. Lanoy, Emilie

    1. Patient-reported tolerability of adverse events in phase 1 trials
      Clémence Henon, Delphine Lissa, Xavier Paoletti, Constance Thibault, Christophe Le Tourneau, Emilie Lanoy, Antoine Hollebecque, Christophe Massard, Jean-Charles Soria, Sophie Postel-Vinay
  2. Laurentiis, Michelino De

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  3. Lebbe, Céleste

    1. Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
      Baptiste Louveau, Jörg Tost, Florence Mauger, Aurélie Sadoux, Marie-Pierre Podgorniak, Alexandre How-Kit, Cécile Pages, Jennifer Roux, Laetitia Da Meda, Céleste Lebbe, Samia Mourah
  4. Leopaldi, Luigi

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  5. Liang, Chen-lu

    1. The effect of adjuvant chemotherapy in male breast cancer: 134 cases from a retrospective study
      Xing-Fei Yu, Chen Wang, Bo Chen, Chen-lu Liang, Dao-bao Chen, Yang Yu, Hong-jian Yang
  6. Lieto, Eva

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  7. Lingjærde, Ole Christian

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  8. Lissa, Delphine

    1. Patient-reported tolerability of adverse events in phase 1 trials
      Clémence Henon, Delphine Lissa, Xavier Paoletti, Constance Thibault, Christophe Le Tourneau, Emilie Lanoy, Antoine Hollebecque, Christophe Massard, Jean-Charles Soria, Sophie Postel-Vinay
  9. Louveau, Baptiste

    1. Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
      Baptiste Louveau, Jörg Tost, Florence Mauger, Aurélie Sadoux, Marie-Pierre Podgorniak, Alexandre How-Kit, Cécile Pages, Jennifer Roux, Laetitia Da Meda, Céleste Lebbe, Samia Mourah
  10. Lund-Iversen, Marius

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  11. Lurås, Hilde

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark

M

  1. Mabilia, Roberto

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  2. Marchetti, Antonio

    1. External quality assessment for EGFR mutations in Italy: improvements in performances over the time
      Nicola Normanno, Francesca Fenizia, Francesca Castiglione, Massimo Barberis, Gian Luigi Taddei, Mauro Truini, Gaetano De Rosa, Carmine Pinto, Antonio Marchetti
  3. Martin, Andrew

    1. Discussing and prescribing expensive unfunded anticancer drugs in Australia
      Deme John Karikios, Linda Mileshkin, Andrew Martin, Danielle Ferraro, Martin R Stockler
  4. Massard, Christophe

    1. Patient-reported tolerability of adverse events in phase 1 trials
      Clémence Henon, Delphine Lissa, Xavier Paoletti, Constance Thibault, Christophe Le Tourneau, Emilie Lanoy, Antoine Hollebecque, Christophe Massard, Jean-Charles Soria, Sophie Postel-Vinay
  5. Matovina-Brko, Gorana

    1. Checkpoint inhibitors in the treatment of urological malignancies
      Lazar S Popovic, Gorana Matovina-Brko, Maja Popovic
  6. Mauger, Florence

    1. Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
      Baptiste Louveau, Jörg Tost, Florence Mauger, Aurélie Sadoux, Marie-Pierre Podgorniak, Alexandre How-Kit, Cécile Pages, Jennifer Roux, Laetitia Da Meda, Céleste Lebbe, Samia Mourah
  7. Melchiorri, Daniela

    1. European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer
      Stefan Cristian Stanel, Jan Sjöberg, Tomas Salmonson, Paolo Foggi, Mariapaola Caleno, Daniela Melchiorri, Iordanis Gravanis, Kyriaki Tzogani, Francesco Pignatti
  8. Mileshkin, Linda

    1. Discussing and prescribing expensive unfunded anticancer drugs in Australia
      Deme John Karikios, Linda Mileshkin, Andrew Martin, Danielle Ferraro, Martin R Stockler
  9. Mocerino, Carmela

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  10. Montesarchio, Vincenzo

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  11. Morgillo, Floriana

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
  12. Mourah, Samia

    1. Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
      Baptiste Louveau, Jörg Tost, Florence Mauger, Aurélie Sadoux, Marie-Pierre Podgorniak, Alexandre How-Kit, Cécile Pages, Jennifer Roux, Laetitia Da Meda, Céleste Lebbe, Samia Mourah
  13. Mælandsmo, Gunhild M

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark

N

  1. Nakken, Sigve

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  2. Nasser, Salah

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  3. Nettuno, Raffaele

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  4. Noguchi, Emi

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura
  5. Normanno, Nicola

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
    2. External quality assessment for EGFR mutations in Italy: improvements in performances over the time
      Nicola Normanno, Francesca Fenizia, Francesca Castiglione, Massimo Barberis, Gian Luigi Taddei, Mauro Truini, Gaetano De Rosa, Carmine Pinto, Antonio Marchetti
  6. Nygaard, Vegard

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  7. Nygaard, Vigdis

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark

O

  1. Omlin, Aurelius

    1. Multiple primary tumours: challenges and approaches, a review
      Alexia Vogt, Sabine Schmid, Karl Heinimann, Harald Frick, Christian Herrmann, Thomas Cerny, Aurelius Omlin
  2. Ono, Makiko

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura
  3. Orditura, Michele

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  4. Oudard, Stephane

    1. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
      Clemence Granier, Eleonore De Guillebon, Charlotte Blanc, Helene Roussel, Cecile Badoual, Elia Colin, Antonin Saldmann, Alain Gey, Stephane Oudard, Eric Tartour

P

  1. Pages, Cécile

    1. Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
      Baptiste Louveau, Jörg Tost, Florence Mauger, Aurélie Sadoux, Marie-Pierre Podgorniak, Alexandre How-Kit, Cécile Pages, Jennifer Roux, Laetitia Da Meda, Céleste Lebbe, Samia Mourah
  2. Paoletti, Xavier

    1. Patient-reported tolerability of adverse events in phase 1 trials
      Clémence Henon, Delphine Lissa, Xavier Paoletti, Constance Thibault, Christophe Le Tourneau, Emilie Lanoy, Antoine Hollebecque, Christophe Massard, Jean-Charles Soria, Sophie Postel-Vinay
  3. Papaccio, Federica

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
  4. Pignatti, Francesco

    1. European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer
      Stefan Cristian Stanel, Jan Sjöberg, Tomas Salmonson, Paolo Foggi, Mariapaola Caleno, Daniela Melchiorri, Iordanis Gravanis, Kyriaki Tzogani, Francesco Pignatti
  5. Pinto, Carmine

    1. External quality assessment for EGFR mutations in Italy: improvements in performances over the time
      Nicola Normanno, Francesca Fenizia, Francesca Castiglione, Massimo Barberis, Gian Luigi Taddei, Mauro Truini, Gaetano De Rosa, Carmine Pinto, Antonio Marchetti
  6. Pisano, Agata

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  7. Podgorniak, Marie-Pierre

    1. Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
      Baptiste Louveau, Jörg Tost, Florence Mauger, Aurélie Sadoux, Marie-Pierre Podgorniak, Alexandre How-Kit, Cécile Pages, Jennifer Roux, Laetitia Da Meda, Céleste Lebbe, Samia Mourah
  8. Popovic, Lazar S

    1. Checkpoint inhibitors in the treatment of urological malignancies
      Lazar S Popovic, Gorana Matovina-Brko, Maja Popovic
  9. Popovic, Maja

    1. Checkpoint inhibitors in the treatment of urological malignancies
      Lazar S Popovic, Gorana Matovina-Brko, Maja Popovic
  10. Postel-Vinay, Sophie

    1. Patient-reported tolerability of adverse events in phase 1 trials
      Clémence Henon, Delphine Lissa, Xavier Paoletti, Constance Thibault, Christophe Le Tourneau, Emilie Lanoy, Antoine Hollebecque, Christophe Massard, Jean-Charles Soria, Sophie Postel-Vinay
  11. Preusser, Matthias

    1. CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology
      Matthias Preusser, Anna S Berghoff, Christiane Thallinger, Christoph Zielinski
  12. Procaccini, Eugenio

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello

R

  1. Ree, Anne Hansen

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  2. Reisse, Claudius H

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  3. Riccardi, Ferdinando

    1. Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
      Michele Orditura, Adriano Gravina, Ferdinando Riccardi, Anna Diana, Carmela Mocerino, Luigi Leopaldi, Alessio Fabozzi, Guido Giordano, Raffaele Nettuno, Pasquale Incoronato, Maria Luisa Barzelloni, Roberta Caputo, Agata Pisano, Giuseppe Grimaldi, Geppino Genua, Vincenzo Montesarchio, Enrico Barbato, Giovanni Iodice, Eva Lieto, Eugenio Procaccini, Roberto Mabilia, Antonio Febbraro, Michelino De Laurentiis, Fortunato Ciardiello
  4. Rodriguez-Vida, Alejo

    1. New treatment options for metastatic renal cell carcinoma
      Alejo Rodriguez-Vida, Thomas E Hutson, Joaquim Bellmunt, Michiel H Strijbos
  5. Roussel, Helene

    1. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
      Clemence Granier, Eleonore De Guillebon, Charlotte Blanc, Helene Roussel, Cecile Badoual, Elia Colin, Antonin Saldmann, Alain Gey, Stephane Oudard, Eric Tartour
  6. Roux, Jennifer

    1. Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
      Baptiste Louveau, Jörg Tost, Florence Mauger, Aurélie Sadoux, Marie-Pierre Podgorniak, Alexandre How-Kit, Cécile Pages, Jennifer Roux, Laetitia Da Meda, Céleste Lebbe, Samia Mourah
  7. Russnes, Hege G

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  8. Ruud, Espen A

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  9. Rødland, Einar A

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark

S

  1. Sadoux, Aurélie

    1. Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
      Baptiste Louveau, Jörg Tost, Florence Mauger, Aurélie Sadoux, Marie-Pierre Podgorniak, Alexandre How-Kit, Cécile Pages, Jennifer Roux, Laetitia Da Meda, Céleste Lebbe, Samia Mourah
  2. Saldmann, Antonin

    1. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
      Clemence Granier, Eleonore De Guillebon, Charlotte Blanc, Helene Roussel, Cecile Badoual, Elia Colin, Antonin Saldmann, Alain Gey, Stephane Oudard, Eric Tartour
  3. Salmonson, Tomas

    1. European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer
      Stefan Cristian Stanel, Jan Sjöberg, Tomas Salmonson, Paolo Foggi, Mariapaola Caleno, Daniela Melchiorri, Iordanis Gravanis, Kyriaki Tzogani, Francesco Pignatti
  4. Santini, Mario

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
  5. Sasso, Ferdinando Carlo

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
  6. Sathermugathevan, Menaka

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  7. Sauer, Torill

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  8. Schmid, Sabine

    1. Multiple primary tumours: challenges and approaches, a review
      Alexia Vogt, Sabine Schmid, Karl Heinimann, Harald Frick, Christian Herrmann, Thomas Cerny, Aurelius Omlin
  9. Seidelman, William E

    1. Where do they come from? A call for complete transparency regarding the origin of human tissues in research
      Sabine Hildebrandt, William E Seidelman
  10. Senkus, Elżbieta

    1. New horizon in breast cancer therapy: highlights from the European Society for Medical Oncology
      Elżbieta Senkus
  11. Shimizu, Chikako

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura
  12. Shimoi, Tatsunori

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura
  13. Shimomura, Akihiko

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura
  14. Silwal-Pandit, Laxmi

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  15. Sjöberg, Jan

    1. European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer
      Stefan Cristian Stanel, Jan Sjöberg, Tomas Salmonson, Paolo Foggi, Mariapaola Caleno, Daniela Melchiorri, Iordanis Gravanis, Kyriaki Tzogani, Francesco Pignatti
  16. Skarpeteig, Veronica

    1. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
      Anne Hansen Ree, Hege G Russnes, Daniel Heinrich, Svein Dueland, Kjetil Boye, Vigdis Nygaard, Laxmi Silwal-Pandit, Olga Østrup, Eivind Hovig, Vegard Nygaard, Einar A Rødland, Sigve Nakken, Janne T Øien, Christin Johansen, Inger R Bergheim, Veronica Skarpeteig, Menaka Sathermugathevan, Torill Sauer, Marius Lund-Iversen, Klaus Beiske, Salah Nasser, Lars Julsrud, Claudius H Reisse, Espen A Ruud, Vivi Ann Flørenes, Kirsten T Hagene, Eline Aas, Hilde Lurås, Siv Johnsen-Soriano, Gry A Geitvik, Ole Christian Lingjærde, Anne-Lise Børresen-Dale, Gunhild M Mælandsmo, Kjersti Flatmark
  17. Soria, Jean-Charles

    1. Patient-reported tolerability of adverse events in phase 1 trials
      Clémence Henon, Delphine Lissa, Xavier Paoletti, Constance Thibault, Christophe Le Tourneau, Emilie Lanoy, Antoine Hollebecque, Christophe Massard, Jean-Charles Soria, Sophie Postel-Vinay
  18. Stanel, Stefan Cristian

    1. European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer
      Stefan Cristian Stanel, Jan Sjöberg, Tomas Salmonson, Paolo Foggi, Mariapaola Caleno, Daniela Melchiorri, Iordanis Gravanis, Kyriaki Tzogani, Francesco Pignatti
  19. Stockler, Martin R

    1. Discussing and prescribing expensive unfunded anticancer drugs in Australia
      Deme John Karikios, Linda Mileshkin, Andrew Martin, Danielle Ferraro, Martin R Stockler
  20. Strijbos, Michiel H

    1. New treatment options for metastatic renal cell carcinoma
      Alejo Rodriguez-Vida, Thomas E Hutson, Joaquim Bellmunt, Michiel H Strijbos

T

  1. Taddei, Gian Luigi

    1. External quality assessment for EGFR mutations in Italy: improvements in performances over the time
      Nicola Normanno, Francesca Fenizia, Francesca Castiglione, Massimo Barberis, Gian Luigi Taddei, Mauro Truini, Gaetano De Rosa, Carmine Pinto, Antonio Marchetti
  2. Tamura, Kenji

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura
  3. Tartour, Eric

    1. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
      Clemence Granier, Eleonore De Guillebon, Charlotte Blanc, Helene Roussel, Cecile Badoual, Elia Colin, Antonin Saldmann, Alain Gey, Stephane Oudard, Eric Tartour
  4. Thallinger, Christiane

    1. CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology
      Matthias Preusser, Anna S Berghoff, Christiane Thallinger, Christoph Zielinski
  5. Thibault, Constance

    1. Patient-reported tolerability of adverse events in phase 1 trials
      Clémence Henon, Delphine Lissa, Xavier Paoletti, Constance Thibault, Christophe Le Tourneau, Emilie Lanoy, Antoine Hollebecque, Christophe Massard, Jean-Charles Soria, Sophie Postel-Vinay
  6. Tost, Jörg

    1. Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
      Baptiste Louveau, Jörg Tost, Florence Mauger, Aurélie Sadoux, Marie-Pierre Podgorniak, Alexandre How-Kit, Cécile Pages, Jennifer Roux, Laetitia Da Meda, Céleste Lebbe, Samia Mourah
  7. Tourneau, Christophe Le

    1. Patient-reported tolerability of adverse events in phase 1 trials
      Clémence Henon, Delphine Lissa, Xavier Paoletti, Constance Thibault, Christophe Le Tourneau, Emilie Lanoy, Antoine Hollebecque, Christophe Massard, Jean-Charles Soria, Sophie Postel-Vinay
  8. Truini, Mauro

    1. External quality assessment for EGFR mutations in Italy: improvements in performances over the time
      Nicola Normanno, Francesca Fenizia, Francesca Castiglione, Massimo Barberis, Gian Luigi Taddei, Mauro Truini, Gaetano De Rosa, Carmine Pinto, Antonio Marchetti
  9. Tsuda, Hitoshi

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura
  10. Tzogani, Kyriaki

    1. European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer
      Stefan Cristian Stanel, Jan Sjöberg, Tomas Salmonson, Paolo Foggi, Mariapaola Caleno, Daniela Melchiorri, Iordanis Gravanis, Kyriaki Tzogani, Francesco Pignatti

V

  1. Vicidomini, Giovanni

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
  2. Viscardi, Giuseppe

    1. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
      Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte, Ferdinando Carlo Sasso, Federica Papaccio, Giuseppe Viscardi, Giovanna Esposito, Raimondo Di Liello, Nicola Normanno, Annalisa Capuano, Liberato Berrino, Giovanni Vicidomini, Alfonso Fiorelli, Mario Santini, Fortunato Ciardiello
  3. Vogt, Alexia

    1. Multiple primary tumours: challenges and approaches, a review
      Alexia Vogt, Sabine Schmid, Karl Heinimann, Harald Frick, Christian Herrmann, Thomas Cerny, Aurelius Omlin

W

  1. Wang, Chen

    1. The effect of adjuvant chemotherapy in male breast cancer: 134 cases from a retrospective study
      Xing-Fei Yu, Chen Wang, Bo Chen, Chen-lu Liang, Dao-bao Chen, Yang Yu, Hong-jian Yang

Y

  1. Yang, Hong-jian

    1. The effect of adjuvant chemotherapy in male breast cancer: 134 cases from a retrospective study
      Xing-Fei Yu, Chen Wang, Bo Chen, Chen-lu Liang, Dao-bao Chen, Yang Yu, Hong-jian Yang
  2. Yonemori, Kan

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura
  3. Yoshida, Masayuki

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura
  4. Yu, Xing-Fei

    1. The effect of adjuvant chemotherapy in male breast cancer: 134 cases from a retrospective study
      Xing-Fei Yu, Chen Wang, Bo Chen, Chen-lu Liang, Dao-bao Chen, Yang Yu, Hong-jian Yang
  5. Yu, Yang

    1. The effect of adjuvant chemotherapy in male breast cancer: 134 cases from a retrospective study
      Xing-Fei Yu, Chen Wang, Bo Chen, Chen-lu Liang, Dao-bao Chen, Yang Yu, Hong-jian Yang
  6. Yunokawa, Mayu

    1. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
      Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura

Z

  1. Zielinski, Christoph

    1. CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology
      Matthias Preusser, Anna S Berghoff, Christiane Thallinger, Christoph Zielinski